Lifevantage Corporation Common Stock (Delaware)

€5.281
EUR
Last updated on --.
24h volume50.59K
24h highest5.4973 EUR
24h lowest5.2729 EUR
24h Price movement-1.77%

LFVN recent prices

24 Hours
-1.77%-€0.09493
30 days
-9.11%-€0.53679
60 days
-1.15%-€0.062136
90 days
-37.73%-€3.247

Key data

Previous close5.3765 EUR
Market cap68.70M EUR
Volume50.59K
P/E ratio15.710000
Dividend yield (TTM)0.03%
Dividend amount0.043150 EUR
Next ex-dividend dateSep 1, 2026
Next payment dateSep 15, 2026
EPS diluted (TTM)0.34520 EUR
Net income (FY)4.38M EUR
Revenue (FY)157.57M EUR
Last report dateAug 27, 2026

About Lifevantage Corporation Common Stock (Delaware)

PHARMACEUTICAL PREPARATIONS
HeadquartersLEHI
Employees (FY)223.00
Revenue per employee (FY)706.60K EUR
Net income per employee (FY)19.63K EUR
Listed onNasdaq
Official website

LFVN conversion tables

LFVNLFVN
EUREUR
0.5 LFVN2.640 EUR
1 LFVN5.281 EUR
5 LFVN26.4 EUR
10 LFVN52.81 EUR
EUREUR
LFVNLFVN
0.5 EUR0.094669 LFVN
1 EUR0.18934 LFVN
5 EUR0.94669 LFVN
10 EUR1.893 LFVN

FAQ

LFVN is trading at €5.281, -1.77% over the last 24 hours. Track live moves on the price chart at the top of this page.
The LFVN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. LFVN is currently trading at €5.281, -1.77% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on LFVN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. LFVN's P/E ratio is currently 15.710000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from LFVN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against LFVN's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Lifevantage Corporation Common Stock (Delaware)'s market cap is currently 68.70M EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume50.59K
24h highest5.4973 EUR
24h lowest5.2729 EUR
24h Price movement-1.77%
LFVNLFVN
EUREUR
Start trade with LFVN Perpetual